US AUTHENTIC TRADING COMPANY (USAT)
In partnership with the PRC government and major commercial stakeholders, US Authentic Trading evaluates hospital and institutional partnerships that facilitate the import and sale of emerging global healthcare brands within the PRC via our powerful and unified purchasing and distribution platform giving access to the entire PRC healthcare ecosystem. We currently on-board and prepare select North American and European brands to sell their healthcare services and products via our sophisticated and accelerated channels. We also equally represent Chinese healthcare companies desiring to expand into the North American and European markets.
WHAT WE DO
USAT maintains an extensive network throughout the Peoples Republic of China (PRC), spanning both corporate and top level government relationships. We work with thought leaders and power brokers at the forefront of the PRC's economic transformation to solve the dual problems of counterfeiting and market penetration, massive pain points that undermine the accelerating demand for high quality consumer brands, healthcare products and services, medical technology, and pharmaceuticals within the ascendant PRC middle and upper classes.
Our solution represents a paradigm shift in security, social marketing, and culturally informed brand creation as well as top down healthcare marketplace access. We go beyond protecting our brands to build a self-reinforcing cycle of growth, available as a premium turnkey solution. You don’t need to trust the PRC: you can trust us.
What we Do
USAT possesses unprecedented access to the PRC healthcare market via direct submissions to national hospital procurement tenders, bonded duty free warehouses, exhibition centers for pre-FDA and/or pre-CFDA device sales, China FDA (NMPA) accelerated approval channels, clinical trial implementation and patient access, educational services for PRC registered physicians, capital investment from PRC to name a few. USAT is able to implement market access strategies, spanning a broad range of medical research networks, medical treatment and device technologies, biological and molecular pharmaceuticals, institutional and education services and inroads for the emergent field of global e-medicine and regenerative medicine including gene therapy and cellular therapy.
Dr. Michael Edwards M.D. PhD—co-founder and CEO of USAT—specializes in the field of advanced cutting edge medical research implementation from molecular genetics to surgical transplantation technology. He’s spent the past decade developing an extensive network of researchers and officials within the PRC healthcare ecosystem, and is a world leader in facilitating the flow of this specialized knowledge between East and West while maintaining the integrity of the intellectual property. Most notably, this has taken the form of a partnership between the PRC government and the USAT team to create an advanced centers for the development and training of next-generation e-medicine practices and technologies at the USAT-Unihealth Shanghai Medical Technology Center.
Within the PRC’s notoriously chaotic markets, USAT provides a network of trusted partners capable of expedited and secure importation, complex healthcare brand development and implementation within the PRC media and social landscapes, and distribution within both cutting-edge mobile and brick-and-mortar facilities spanning the entire nation.
USAT possesses exclusive rights for US partnerships seeking to leverage these platforms, and can therefore ensure that our family of brands maintains its standards of quality and integrity while scaling their presence within China. Furthermore, our partnerships with the PRC government allow for expedited trademarking processes and the efficient management of conflicts with those who seek to infringe upon foreign brand identities before market entry.